Edward Tobinick

2.4k total citations
30 papers, 1.7k citations indexed

About

Edward Tobinick is a scholar working on Neurology, Neurology and Physiology. According to data from OpenAlex, Edward Tobinick has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 10 papers in Neurology and 10 papers in Physiology. Recurrent topics in Edward Tobinick's work include Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Alzheimer's disease research and treatments (9 papers) and S100 Proteins and Annexins (5 papers). Edward Tobinick is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Alzheimer's disease research and treatments (9 papers) and S100 Proteins and Annexins (5 papers). Edward Tobinick collaborates with scholars based in United States, Canada and Netherlands. Edward Tobinick's co-authors include Hyman Gross, A Weinberger, Venita DePuy, H. R. Schelbert, Hartmut Henning, M. M. LeWinter, Andrew Taylor, William L. Ashburn, Joel S. Karliner and Tracey A. Ignatowski and has published in prestigious journals such as Circulation, Drug Discovery Today and Brain Behavior and Immunity.

In The Last Decade

Edward Tobinick

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Tobinick United States 22 594 588 420 300 201 30 1.7k
P. Jouanny France 14 1.0k 1.7× 413 0.7× 551 1.3× 145 0.5× 161 0.8× 50 2.0k
Jin Jun Luo United States 22 753 1.3× 475 0.8× 641 1.5× 209 0.7× 410 2.0× 97 2.5k
Wei Qin China 22 540 0.9× 404 0.7× 540 1.3× 355 1.2× 214 1.1× 89 1.8k
Yong Ji China 22 583 1.0× 239 0.4× 409 1.0× 196 0.7× 122 0.6× 81 1.5k
Liying Jiang China 22 998 1.7× 591 1.0× 581 1.4× 66 0.2× 230 1.1× 69 2.5k
Yoichi Morofuji Japan 20 294 0.5× 557 0.9× 427 1.0× 433 1.4× 160 0.8× 120 1.8k
Nimish K. Acharya United States 17 347 0.6× 386 0.7× 508 1.2× 223 0.7× 158 0.8× 28 1.4k
Aric F. Logsdon United States 20 363 0.6× 529 0.9× 535 1.3× 572 1.9× 189 0.9× 33 1.8k
Richard Batrla Switzerland 15 1.2k 2.0× 339 0.6× 494 1.2× 205 0.7× 137 0.7× 24 2.4k
Kensuke Sasaki Japan 22 727 1.2× 462 0.8× 835 2.0× 280 0.9× 174 0.9× 69 2.0k

Countries citing papers authored by Edward Tobinick

Since Specialization
Citations

This map shows the geographic impact of Edward Tobinick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Tobinick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Tobinick more than expected).

Fields of papers citing papers by Edward Tobinick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Tobinick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Tobinick. The network helps show where Edward Tobinick may publish in the future.

Co-authorship network of co-authors of Edward Tobinick

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Tobinick. A scholar is included among the top collaborators of Edward Tobinick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Tobinick. Edward Tobinick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tobinick, Edward, et al.. (2024). Perispinal etanercept stroke trial design: PESTO and beyond. Expert Opinion on Biological Therapy. 24(10). 1–14. 1 indexed citations
2.
Tobinick, Edward, et al.. (2022). Rapid improvement in severe long COVID following perispinal etanercept. Current Medical Research and Opinion. 38(12). 2013–2020. 11 indexed citations
3.
4.
Tobinick, Edward. (2016). Perispinal Delivery of CNS Drugs. CNS Drugs. 30(6). 469–480. 23 indexed citations
5.
Tobinick, Edward, et al.. (2014). Immediate Neurological Recovery Following Perispinal Etanercept Years After Brain Injury. Clinical Drug Investigation. 34(5). 361–366. 32 indexed citations
6.
Tobinick, Edward, et al.. (2012). Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury. CNS Drugs. 26(12). 1051–1070. 102 indexed citations
7.
Tobinick, Edward. (2012). Deciphering the Physiology Underlying the Rapid Clinical Effects of Perispinal Etanercept in Alzheimers Disease. Current Alzheimer Research. 9(1). 99–109. 24 indexed citations
8.
Tobinick, Edward. (2010). El sistema venoso cerebroespinal: Anatomía, fisiología e implicaciones clínicas. Dialnet (Universidad de la Rioja). 6(1). 1. 1 indexed citations
9.
Tobinick, Edward. (2010). Perispinal etanercept: a new therapeutic paradigm in neurology. Expert Review of Neurotherapeutics. 10(6). 985–1002. 49 indexed citations
10.
Tobinick, Edward. (2009). Tumour Necrosis Factor Modulation for Treatment of Alzheimerʼs Disease. CNS Drugs. 23(9). 713–725. 92 indexed citations
11.
Tobinick, Edward, Kai Chen, & Xiaoyuan Chen. (2009). Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging. BMC Research Notes. 2(1). 28–28. 27 indexed citations
12.
Tobinick, Edward. (2009). The value of drug repositioning in the current pharmaceutical market. Drug News & Perspectives. 22(1). 119–119. 146 indexed citations
13.
Tobinick, Edward & Hyman Gross. (2008). Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. Journal of Neuroinflammation. 5(1). 2–2. 194 indexed citations
14.
Tobinick, Edward. (2008). Perispinal etanercept for neuroinflammatory disorders. Drug Discovery Today. 14(3-4). 168–177. 39 indexed citations
15.
Tobinick, Edward & Hyman Gross. (2008). Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease. BMC Neurology. 8(1). 27–27. 79 indexed citations
16.
Tobinick, Edward. (2007). Paradigm Shift: Excess TNF-Alpha Emerges as a Key Therapeutic Target in Alzheimer's Disease. PubMed Central. 9(3). 17. 6 indexed citations
17.
Tobinick, Edward. (2007). Perispinal Etanercept for Treatment of Alzheimers Disease. Current Alzheimer Research. 4(5). 550–552. 47 indexed citations
18.
Tobinick, Edward, et al.. (2004). Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients. Current Medical Research and Opinion. 20(7). 1075–1085. 75 indexed citations
19.
Tobinick, Edward. (2003). Targeted etanercept for discogenic neck pain: Uncontrolled, open-label results in two adults. Clinical Therapeutics. 25(4). 1211–1218. 20 indexed citations
20.
Tobinick, Edward, et al.. (2003). Perispinal TNF-alpha inhibition for discogenic pain. Swiss Medical Weekly. 133(1112). 170–170. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Jouanny Breakdown of academic impact, for papers by Jin Jun Luo Breakdown of academic impact, for papers by Wei Qin Breakdown of academic impact, for papers by Yong Ji Breakdown of academic impact, for papers by Liying Jiang Breakdown of academic impact, for papers by Yoichi Morofuji Breakdown of academic impact, for papers by Nimish K. Acharya Breakdown of academic impact, for papers by Aric F. Logsdon Breakdown of academic impact, for papers by Richard Batrla Breakdown of academic impact, for papers by Kensuke Sasaki
Rankless by CCL
2026